Global Collagen & Gelatin Market - 2022-2029

Market Overview

Collagen & Gelatin Market size was valued US$ 5010.6 million in 2021 and is estimated to reach US$ 7019.6 million by 2029, growing at a CAGR of 5.0% during the forecast period (2022-2029).

Collagen peptide is a cold-soluble and easily digested type of collagen. It is the essential building block that makes up about 30% of the human body's protein. Collagen peptide contains higher concentrations of glycine, hydroxyproline, and proline. Likewise, gelatin is primarily composed of two components, such as proline and amino acid glycine. It is derived from animal bones, lungs, and fibrous tissues. Gelatin is essential for proper hair, skin, and nail development, weight control, and optimal immune function.

Market Dynamics

The global collagen & gelatin market is growing due to the increasing prevalence of chronic diseases, rapid growth in ageing populations, and increased funding for regenerative medicines are essential factors driving the global demand for collagen & gelatin for regenerative medication. Moreover, emerging economies, such as Asia-Pacific and South America, offer significant opportunities in these regions, mainly due to increased life expectancy resulting in chronic diseases and increased meat production.

Rising prevalence of chronic diseases drives the growth of the market

Collagen & gelatin are present in the human body, particularly in the skin and bones. The normal development of collagen in the body declines after a certain age. Lack of collagen causes chronic diseases such as osteoporosis, bone and joint pain, chronic wounds, cardiovascular diseases, and other neurodegenerative disorders. These chronic diseases result in organ and tissue destruction, leading to the creation of treatments that can restore tissues. For instance, according to the centres for disease control and prevention (CDC), in United States, cardiovascular diseases are the leading cause of death globally, accounting for 697,000 people deaths per year in 2020.

Strict regulations and the presence of substitutes for collagen & gelatin

Collagen derived from bovine and porcine sources carries the risk of disease transmission, which is the primary constraint on the demand for collagen & gelatin. Another aspect that hinders the target market is the tight limitations on these supplements by the European Union. Moreover, the increasing use of biomaterials, which alternate to collagen & gelatin, is a significant challenge for the growth of the collagen & gelatin market in the forecast period.

COVID-19 Impact Analysis

COVID-19 has had a negative impact on different markets around the world. Due to sudden locking restrictions and a ban on airlines, there is a split in the movement of supply chain and manufacturing units. These factors negatively disrupted market shares. Collagen has played a significant role in the war against diseases such as COVID-19 in recent studies. These results are beneficial in developing a drug or vaccine that is a critical part of the current situation. These attributes would boost the growth of the market in the future.

Industry Analysis

The global collagen & gelatin market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis.

Segment Analysis

The collagen segment is expected to hold the largest market share in global collagen & gelatin market

The collagen segment dominating growth is primarily driven because increasing end-use applications such as growing usage in the food & beverage industry and an upsurge in demand from the cosmetics industry. Although, partial hydrolysis of collagen contributes to the formation of gelatin. The gelatin segment dominates the market due to its high use in the food & beverage, cosmetics, and medical industries. Also, the growing number of chronic disease patients and the increasing number of ageing shares of the entire population in the developing countries are further estimated to lead the growth of the segment worldwide during the forecast period.

Geographical Analysis

North America region holds the largest market share in the global collagen & gelatin market

North America was held a dominant position in the global collagen & gelatin market in 2021. In North America, the US is expected to represent considerable growth during the forecast period. In the US, the collagen & gelatin market is projected to grow exponentially due to the rising prevalence of chronic diseases in the region. Moreover, South America is expected to represent significant growth in terms of value during the forecast period. Availability of government and private funding for R&D is expected to propel market growth across the region. Collagen & Gelatin market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the region's ageing population's development, especially in India and China. Moreover, increasing research on collagen & gelatin-based products is the primary factor creating a lucrative opportunity for the growth of the Asia Pacific collagen & gelatin market in the forecast years.

Competitive Landscape

The collagen & gelatin market is highly competitive, owing to big market players in the industry. The key collagen & gelatin players which are contributing to the growth of the global market include Rousselot, Collagen Solutions Plc, Darling Ingredients Inc., Ewald-Gelatine GmbH, GELITA AG, GELNEX, Holista Colltech Limited, LAPI GROUP SpA, Tessenderlo Group, Trobas Gelatine B.V. among others. The major players are adopting new product development and expansion strategies for global growth in the collagen & gelatin market.

Key Companies to Watch

Rousselot:

Overview: Rousselot is one the global leader in collagen-based solutions* for the food, health & nutrition, (bio)medical, and pharmaceutical sectors. The company offers Peptan, Peptan IIm, ProTake, Rousselot world-class gelatins, SiMoGel, StabiCaps, Synergy Systems, and X-Pure. It primarily serves nutrition and health, biomedical, food, pharmaceuticals, and technical market companies. Rousselot was founded in France in 1891 by Edouard Rousselot.

Product Portfolio:

X-Pure gelatins offer premium-grade solutions, with tunable functionalities and low endotoxins ≤ 10 EU/g, and are one of the most favorable biomaterials for tissue or stem cell bioengineering. X-Pure products are customizable and include X-Pure Gelatin, X-Pure GelMA, and X-Pure GelDAT.

The global collagen & gelatin market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.